Fundraising Fox

Glycoregimmune

San Diego, US · Founded 2018 · Delaware corporation

Healthtech

Founders & leadership

WM
Walter Marc HertzExecutive
OG
Oppel GreefExecutive
VK
Vipin Kumar ChaturvediExecutive

Board

RW
Raymond WattBoard director
AA
Albert AgroBoard director
AV
Abraham Van WykBoard director

Reported raises · per SEC filings

Form D private placements

$26.9M disclosed across 4 rounds · 2015–2023

▶$15.6MraisedApr 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Walter Marc HertzExecutive Officer, Director
Offering amount
$15.6M
Amount sold
$15.6M
Sales commissions
$245K
Placement agents
Ecoban Securities Corporation
First sale
Apr 2023
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedDec 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • ABRAHAM VAN WYCKDirector
  • WALTER MARC HERTZExecutive Officer, Director
  • VIPIN KUMAR CHATURVEDIExecutive Officer, Director
  • ALBERT AGROExecutive Officer, Director
Offering amount
$2.5M
Amount sold
$1.3M
Sales commissions
$25K
Placement agents
ECOBAN SECURITIES CORPORATION
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.7MraisedNov 2018 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • W MARC HERTZExecutive Officer, Director
  • GERALD YAKATANDirector
  • SEAN G EDWARDSExecutive Officer
  • ALBERT AGRODirector
  • VIPIN KUMARDirector
  • ABRAHAM VAN WYCKDirector
Offering amount
$5.7M
Amount sold
$5.7M
First sale
Nov 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.4MraisedApr 2015 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Raymond WattDirector
  • Walter Marc HertzExecutive Officer, Director
  • Albert AgroDirector
  • Oppel GreefExecutive Officer
  • Abraham Van WykDirector
  • Vipin Kumar ChaturvediExecutive Officer, Director
Offering amount
$6.4M
Amount sold
$4.4M
First sale
Apr 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

San Diego biotech Glycoregimmune raises $4.3 million for natural killer T cell-based therapy - MedCity Newsmedcitynews.com · Apr 2015

Frequently asked questions

How much funding has Glycoregimmune raised?
Glycoregimmune has disclosed $26.9M raised across 4 rounds.
Where is Glycoregimmune headquartered?
Glycoregimmune is headquartered in San Diego, US.